Business & Markets: India — Today

₹15,184 crore — Sun Pharma's Q1 FY27 revenue, up 10% year-on-year, as domestic and emerging markets cushion a US generics slowdown.

Titan Company reported a stronger-than-expected June quarter, emerging as a key earnings winner amid a mixed earnings day.
Delhivery saw Q1 revenue jump 28% to ₹2,931 crore, but net profit collapsed 65% to ₹32 crore, raising margin concerns.
Sun Pharma posted a 10% revenue rise, with India...

17d ago

Ask AI about this

Upgrade to Premium for unlimited AI-powered summaries and full content access.

Cancel anytime. No commitment.

Share

Business

Positive

₹15,184 crore — Sun Pharma's Q1 FY27 revenue, up 10% year-on-year, as domestic and emerging markets cushion a US generics slowdown.

Titan Company reported a stronger-than-expected June quarter, emerging as a key earnings winner amid a mixed earnings day.
Delhivery saw Q1 revenue jump 28% to ₹2,931 crore, but net profit collapsed 65% to ₹32 crore, raising margin concerns.
Sun Pharma posted a 10% revenue rise, with India...

17d ago

Ask AI about this

Upgrade to Premium for unlimited AI-powered summaries and full content access.

Cancel anytime. No commitment.

Share

Loading...